BIOMAT Database Logo BIOMAT Database Logo

Pathogen inactivation of labile blood products. 2001

UI MeSH Term Description Entries
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001781 Blood Component Removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor. Apheresis,Pheresis,Aphereses,Blood Component Removals,Phereses,Removal, Blood Component
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D004203 Disinfection Rendering pathogens harmless through the use of heat, antiseptics, antibacterial agents, etc.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D016913 Blood Component Transfusion The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in PLASMAPHERESIS and types of CYTAPHERESIS; (PLATELETPHERESIS and LEUKAPHERESIS) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor. Blood Component Transfusions,Component Transfusion, Blood,Component Transfusions, Blood,Transfusion, Blood Component,Transfusions, Blood Component
D017848 Blood-Borne Pathogens Infectious organisms, including pathogenic bacteria, viruses, and fungi, that are present in the BLOOD. Blood-Borne Pathogen,Bloodborne Pathogen,Pathogens, Blood-Borne,Bloodborne Pathogens

Related Publications

Pathogen inactivation of labile blood products.
June 2001, Transfusion medicine (Oxford, England),
Pathogen inactivation of labile blood components.
June 2001, Transfusion medicine (Oxford, England),
[Pathogen inactivation in labile blood products: transfusion safety and economic impact].
January 2006, Bulletin de l'Academie nationale de medecine,
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP].
May 2009, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
Pathogen inactivation in blood products.
January 2002, Current medicinal chemistry,
[Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety].
December 2010, Bulletin de l'Academie nationale de medecine,
Phenothiazinium derivatives for pathogen inactivation in blood products.
January 2007, Journal of photochemistry and photobiology. B, Biology,
[Leukodepletion of labile blood products].
January 1999, Annales pharmaceutiques francaises,
[Indications for labile blood products].
June 2001, La Revue du praticien,
[Leukocyte depletion of labile blood products].
January 1987, Revue francaise de transfusion et immuno-hematologie,
Copied contents to your clipboard!